Skip to main content
رجوع
ORIC logo

ORIC Pharmaceuticals, Inc.

جودة البيانات: 100%
ORIC
NASDAQ Healthcare Biotechnology
KWD 11.13
▼ KWD 0.03 (-0.27%)
القيمة السوقية: 1.12B
نطاق اليوم
KWD 10.59 KWD 11.62
نطاق 52 أسبوعًا
KWD 3.90 KWD 14.93
حجم التداول
1,407,716
متوسط 50 يوم / 200 يوم
KWD 11.52 / KWD 10.97
الإغلاق السابق
KWD 11.16

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -8.6 0.4
P/B 2.9 2.9
ROE % -41.3 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.0 0.2

النقاط الرئيسية

Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -114.08M
PEG of 0.28 suggests growth is underpriced

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-41.27%
ROIC-27.09%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.03
Current Ratio14.13
Interest Coverage0.00

التقييم

P/E Ratio
-8.63
P/B Ratio2.91
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -129.47M
ROE -41.27% ROA -31.50%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -114.08M
ROIC -27.09% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.03 Current Ratio 14.13
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -8.63 P/B Ratio 2.91
P/S Ratio N/A PEG Ratio 0.28
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.12B Enterprise Value 1.08B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -129.47M -127.85M -100.70M -89.12M -78.72M
EPS (Diluted) -1.47 -1.83 -1.96 -2.25 -2.07
Gross Profit -1.22M -1.11M -1.03M 0.0 0.0
Operating Income -143.00M -142.90M -110.78M -91.77M -78.87M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 411.00M 274.14M 254.69M 250.36M 298.64M
Total Liabilities 26.64M 31.02M 30.60M 28.01M 25.67M
Shareholders' Equity 384.36M 243.12M 224.09M 222.35M 272.98M
Total Debt 11.55M 3.18M 10.21M 12.10M 1.93M
Cash & Equivalents 45.67M 59.41M 23.38M 66.84M 226.01M
Current Assets 288.47M 262.25M 212.60M 210.46M 240.52M
Current Liabilities 20.42M 24.85M 20.46M 15.39M 15.15M